GlassScriptPhysician profile
Kirk Woelffer
NPI 1275580862
$3,705.96
in general payments reported to CMS, 2019-2025
40 companies · $932 in 2025
The $932 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $1,039 · 2021: $148 · 2022: $305 · 2023: $337 · 2024: $443 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,711.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $853.31 | 2019-2021 | |
| Smith+Nephew, INC. | $328.62 | 2019-2025 | Grafix Pl, Stravix, Stravix Pl |
| Convatec INC. | $263.41 | 2023-2025 | |
| Amgen INC. | $207.58 | 2024-2025 | Krystexxa |
| Lifenet Health | $171.25 | 2025 | Theragenesis Wound Matrix |
| Organogenesis INC. | $152.65 | 2019-2025 | Apligraf |
| Horizon Therapeutics Plc | $137.64 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $129.41 | 2019-2025 | Proclaim, Eterna |
| Paratek Pharmaceuticals, INC. | $125.56 | 2021-2024 | Nuzyra |
| Ossio INC | $119.96 | 2022 | |
| Tactile Systems Technology INC | $110.43 | 2025 | Flexitouch Plus, Nimbl |
| Ibsa Pharma INC. | $103.21 | 2024-2025 | Licart, Tirosint, Flector |
| Bioventus LLC | $88.73 | 2021-2025 | Exogen Ultrasound Bone Healing System, Stimrouter Implantable Kit |
| Cardiovascular Systems INC. | $83.29 | 2020 | |
| Averitas Pharma INC. | $81.06 | 2025 | Qutenza |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $75.24 | 2025 | |
| Grt US Holding, INC. | $70.42 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $66.89 | 2020-2023 | Jublia |
| Arthrosurface Incorporated | $58.90 | 2019 | |
| Medtronic, INC. | $58.55 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Acera Surgical, INC. | $43.03 | 2024 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $42.26 | 2025 | |
| Depuy Synthes Sales INC. | $40.27 | 2024-2025 | Motoband |
| Sandoz INC. | $37.63 | 2019-2020 | |
| Globus Medical, INC. | $33.72 | 2025 | Senza |
| Arteriocyte Medical Systems, INC. | $29.47 | 2019 | |
| Aroa Biosurgery Incorporated | $23.26 | 2025 | |
| Biocomposites INC | $18.74 | 2023 | Stimulan |
| Integra Lifesciences Corporation | $18.34 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baudax Bio INC. | $15.80 | 2020 | |
| Melinta Therapeutics, LLC | $14.99 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.88 | 2024 | Iovera, Zilretta, Exparel |
| Zyla Life Sciences, INC. | $13.91 | 2019 | |
| Osiris Therapeutics INC. | $12.60 | 2019 | |
| Medartis INC. | $12.38 | 2019 | |
| Boston Scientific Corporation | $11.62 | 2019 | |
| Merck Sharp & Dohme LLC | $10.97 | 2019 | |
| Next Science LLC | $10.95 | 2023 | Xperience, Surgx, Blastx |
| Kerecis Limited | $9.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $5.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Woelffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.